you are here:

Ranbaxy Laboratories Ltd.

BSE: 500359 | NSE: RANBAXY | Series: NA | ISIN: INE015A01028 | SECTOR: Pharmaceuticals

BSE Live

Apr 01, 16:00
859.90 0.00 (0.00%)
Volume
No Data Available
308,222
  • Prev. Close

    859.90

  • Open Price

    814.90

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Ranbaxy Laboratories is not traded on BSE in the last 30 days

NSE Live

Apr 01, 15:59
859.80 0.00 (0.00%)
Volume
No Data Available
5,415,702
  • Prev. Close

    859.80

  • Open Price

    814.70

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    859.80 (9924)

Ranbaxy Laboratories is not traded on NSE in the last 30 days

Financials

2021 2020 2019 2018 2017
Nine Months Results of Ranbaxy Laboratories (in Rs. Cr.) Dec '14 Sep '13 Sep '12 Sep '11 Sep '10  
Net Sales/Income from operations 4,346.18 4,104.82 4,711.02 3,646.91 4,570.74  
Other Operating Income 150.98 141.54 151.01 155.49 --  
Total Income From Operations 4,497.16 4,246.36 4,862.02 3,802.40 4,570.74  
EXPENDITURE  
Consumption of Raw Materials 930.80 1,237.71 1,119.74 1,406.94 1,254.79  
Purchase of Traded Goods 640.13 538.51 618.36 460.72 --  
Increase/Decrease in Stocks 249.98 -95.71 -39.28 -168.94 -149.27  
Power & Fuel -- -- -- -- --  
Employees Cost 806.29 776.54 756.10 678.00 583.41  
Depreciation 180.61 184.34 139.77 142.55 163.40  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 1,450.75 2,010.08 1,859.06 1,519.90 1,574.59  
P/L Before Other Inc. , Int., Excpt. Items & Tax 238.60 -405.12 408.27 -236.77 1,143.82  
Other Income 63.54 127.72 172.49 226.67 438.53  
P/L Before Int., Excpt. Items & Tax 302.14 -277.40 580.76 -10.10 1,582.35  
Interest 428.04 317.82 162.70 41.88 155.58  
P/L Before Exceptional Items & Tax -125.90 -595.21 418.07 -51.98 1,426.77  
Exceptional Items -43.13 -785.68 35.69 -286.37 --  
P/L Before Tax -169.03 -1,380.89 453.76 -338.35 1,426.77  
Tax 864.59 -- -- 3.38 415.84  
P/L After Tax from Ordinary Activities -1,033.62 -1,380.89 453.76 -341.73 1,010.93  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- 82.56  
Net Profit/(Loss) For the Period -1,033.62 -1,380.89 453.76 -341.73 1,093.49  
Equity Share Capital 212.24 211.57 211.13 210.75 210.38  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS -24.38 -32.66 10.76 -8.11 26.00  
Diluted EPS -24.38 -32.66 10.72 -8.11 22.79  
EPS After Extra Ordinary  
Basic EPS. -24.38 -32.66 10.76 -8.11 26.00  
Diluted EPS. -24.38 -32.66 10.72 -8.11 22.79  
Public Share Holding  
No Of Shares (Crores) 15.63 14.28 14.50 14.55 14.62  
Share Holding (%) 36.77 33.75 34.35 34.51 34.75  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores) 26.87 26.87 26.87 26.87 26.87  
- Per. of shares (as a % of the total sh. of prom. and promoter group) 100.00 100.00 100.00 100.00 100.00  
- Per. of shares (as a % of the total Share Cap. of the company) 63.22 63.51 63.64 63.75 63.86  
Source : Dion Global Solutions Limited